, Volume 6, Issue 3, pp 177-183

Hepatocellular carcinoma: Epidemic and treatment

Rent the article at a discount

Rent now

* Final gross prices may vary according to local VAT.

Get Access


Hepatocellular carcinoma remains a worldwide epidemic. Survival rates are poor; however, oncologists are able to offer regional therapies to those patients who present with early disease. Prevention through vaccination remains a mainstay of this epidemic. New staging systems that incorporate important information about tumor characteristics and liver disease improve our ability to prognosticate and treat these patients.